Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study

Figure 3

Mean IV Iron DOTs/100 PDs use (with 95% CI) from 2006–2008 (by each quarter).